Assessment of Coronary Flow Reserve by PET-H215O and FFR. Comparison With Dynamic Acquisition Using CZT Camera (WATERDAY)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02278497
Recruitment Status : Unknown
Verified July 2015 by University Hospital, Caen. Recruitment status was: Recruiting
The study will assess coronary flow reserve by PET-H215O and FFR in patients suspected of coroanry artery disease. This a comparative study with dynamic acquisition using CZT camera and 99mcTc-mibi. 20 patients will have those measurements.
Condition or disease
Coronary Artery Disease
Other: ASSESSMENT OF CORONARY FLOW RESERVE BY PET-H215O AND FFR
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 80 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patient between 18 and 80 years
Suspected coronary disease and / or coronary syndrome patient ST-
Patient who has been informed of the study and has given his informed consent
Patient affiliated to a social security system.
Patient having no coronary disease at coronary angiography with FFR on the 3 main epicardial arteries (absence of ≥ 50% stenosis of at least one artery)
Delay of Care grater than 30 days between the PET and SPECT imaging and the diagnostic coronary angiography
Patient with a recent history of myocardial infarction and STEMI, unstable angina
Patient with extra-cardiac disease whose prognosis can interfere with the treatment decision
Pregnant or lactating women
Patient allergic to contrast products during coronary angiography
Patient with MDRD clearance les than 60 ml / min
Patient Under guardianship, or unable to understand the purpose of the study